BTG1 might be employed as a biomarker for carcinogenesis and a target for gene therapy in colorectal cancers
Shuang Zhao(Guiyang Medical University), Hua‐chuan Zheng(Chengde Medical University)
Cited by 29
Related Papers
The molecular mechanisms of chemoresistance in cancers
|Oncotarget|2017|599
Inhibition of chaperone‑mediated autophagy reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer
|Molecular Medicine Reports|2021|32
Effects of Beclin 1 overexpression on aggressive phenotypes of colon cancer cells
|Oncology Letters|2018|23
The Suppressing Effects of Dkk3 Expression on Aggressiveness and Tumorigenesis of Colorectal Cancer
|Frontiers in Oncology|2020|19
RNF180 weakened the lipid droplet formation and subsequent chemoresistance by destabilizing ACC1 and ACLY in esophageal cancer
|Frontiers in Pharmacology|2025|1